RECRUITING

The Positively Quit Trial for Smoking Cessation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main goal of the present study is to determine if a smoking cessation program designed for people living with certain chronic conditions and delivered via videoconferencing groups works better than a control condition--a program that is not designed to help with smoking but that does have the same number of group contact hours as the other program (this program is called the Attention Matched Control condition; AMC) for helping people with certain health conditions stop smoking. People in both groups will receive brief advice to quit and an offer of nicotine replacement therapy patches (NRT), as well as 12 videoconferencing group sessions. The team will measure smoking behavior over a one-year period and compare smoking rates for the treatment condition against AMC to see if the treatment condition is better at getting people living with certain health conditions to quit smoking.

Official Title

The Positively Quit Trial: Addressing Disproportionate Smoking Rates Among People Living With HIV

Quick Facts

Study Start:2020-06-10
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04449458

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * greater than or equal to age 18 (as NRT is not FDA approved for adolescents)
  2. * self-report smoking cigarettes
  3. * positive cotinine test
  4. * motivated to quit
  5. * own a smart phone, laptop, desktop, or tablet computer
  6. * able to join group from a private space with Internet access
  7. * demonstrate the ability to connect to the HIPAA-compliant videoconferencing system, Zoom, over the internet h) speak English i) living in the US j) living with certain health conditions
  1. * pregnant, breastfeeding, or have other contraindications to NRT
  2. * receiving other tobacco treatment, or
  3. * inability to communicate coherently in English during the video-conferencing test or other pre-enrollment interactions

Contacts and Locations

Study Contact

Catheryn Flores, MPH
CONTACT
813-396-2014
catherynf@usf.edu
Shanna Hunt
CONTACT
sphunt@usf.edu

Principal Investigator

Stephanie L Marhefka, PhD
PRINCIPAL_INVESTIGATOR
University of South Florida

Study Locations (Sites)

University of South Florida, College of Nursing
Tampa, Florida, 33612
United States

Collaborators and Investigators

Sponsor: University of South Florida

  • Stephanie L Marhefka, PhD, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-06-10
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2020-06-10
Study Completion Date2026-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cigarette Smoking